{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:29:15Z","timestamp":1775597355036,"version":"3.50.1"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2011,4,29]],"date-time":"2011-04-29T00:00:00Z","timestamp":1304035200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0019499","type":"journal-article","created":{"date-parts":[[2011,4,29]],"date-time":"2011-04-29T21:31:16Z","timestamp":1304112676000},"page":"e19499","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":185,"title":["Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production"],"prefix":"10.1371","volume":"6","author":[{"given":"Michael A.","family":"Curran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myoungjoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Welby","family":"Montalvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aymen","family":"Al-Shamkhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,4,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1084\/jem.183.6.2533","article-title":"CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.","volume":"183","author":"MF Krummel","year":"1996","journal-title":"J Exp Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1126\/science.1131078","article-title":"Reversal of the TCR stop signal by CTLA-4.","volume":"313","author":"H Schneider","year":"2006","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function.","volume":"322","author":"K Wing","year":"2008","journal-title":"Science"},{"key":"ref4","article-title":"Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors.","author":"MA Curran","year":"2009","journal-title":"Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1084\/jem.190.3.355","article-title":"Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte\/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.","volume":"190","author":"A van Elsas","year":"1999","journal-title":"J Exp Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1084\/jem.186.1.47","article-title":"4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.","volume":"186","author":"WW Shuford","year":"1997","journal-title":"J Exp Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-065X.2009.00765.x","article-title":"Immune regulation by 4-1BB and 4-1BBL: complexities and challenges.","volume":"229","author":"C Wang","year":"2009","journal-title":"Immunol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1189\/jlb.1003491","article-title":"4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells.","volume":"75","author":"BK Choi","year":"2004","journal-title":"J Leukoc Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.4049\/jimmunol.179.11.7295","article-title":"Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling.","volume":"179","author":"KG Elpek","year":"2007","journal-title":"J Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1158\/0008-5472.CAN-05-2128","article-title":"Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity.","volume":"66","author":"E Kocak","year":"2006","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.4049\/jimmunol.173.4.2428","article-title":"The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells.","volume":"173","author":"G Zheng","year":"2004","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1002\/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M","article-title":"Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.","volume":"32","author":"VY Taraban","year":"2002","journal-title":"Eur J Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/blood-2004-06-2080","article-title":"Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells.","volume":"105","author":"J Kim","year":"2005","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clim.2007.07.005","article-title":"Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb.","volume":"125","author":"B Li","year":"2007","journal-title":"Clin Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm0697-682","article-title":"Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors.","volume":"3","author":"I Melero","year":"1997","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1172\/JCI27745","article-title":"CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.","volume":"116","author":"SA Quezada","year":"2006","journal-title":"J Clin Invest"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1182\/blood-2008-06-160945","article-title":"IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response.","volume":"112","author":"MP Rubinstein","year":"2008","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1002\/eji.200737126","article-title":"Characterization of mouse CD4 T cell subsets defined by expression of KLRG1.","volume":"37","author":"N Beyersdorf","year":"2007","journal-title":"Eur J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1158\/0008-5472.CAN-04-0757","article-title":"High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.","volume":"64","author":"P Serafini","year":"2004","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors.","volume":"107","author":"MA Curran","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/eji.200838208","article-title":"Optimising anti-tumour CD8 T-cell responses using combinations of immunomodulatory antibodies.","volume":"38","author":"JC Gray","year":"2008","journal-title":"Eur J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1172\/JCI32426","article-title":"Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent.","volume":"117","author":"B Zhang","year":"2007","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1084\/jem.20082492","article-title":"Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies.","volume":"206","author":"KS Peggs","year":"2009","journal-title":"J Exp Med"},{"issue":"Suppl 4","key":"ref24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1634\/theoncologist.13-S4-2","article-title":"The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation.","volume":"13","author":"JD Wolchok","year":"2008","journal-title":"Oncologist"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0019499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:11:28Z","timestamp":1589026288000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0019499"}},"subtitle":[],"editor":[{"given":"Matthias G.","family":"von Herrath","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,4,29]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0019499","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,29]]}}}